MetLife Investment Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,275
| Closed | -$93.2K | – | 2938 |
|
|
2024
Q1 | $93.2K | Sell |
36,275
-10,418
| -22% | -$26.8K | ﹤0.01% | 2572 |
|
|
2023
Q4 | $95.3K | Hold |
46,693
| – | – | ﹤0.01% | 2630 |
|
|
2023
Q3 | $80.3K | Hold |
46,693
| – | – | ﹤0.01% | 2695 |
|
|
2023
Q2 | $91.1K | Buy |
+46,693
| New | +$91.1K | ﹤0.01% | 2732 |
|
|
2022
Q1 | – | Sell |
-15,799
| Closed | -$203K | – | 2778 |
|
|
2021
Q4 | $203K | Buy |
15,799
+5,410
| +52% | +$69.6K | ﹤0.01% | 2045 |
|
|
2021
Q3 | $112K | Sell |
10,389
-6,065
| -37% | -$65.5K | ﹤0.01% | 2394 |
|
|
2021
Q2 | $150K | Buy |
16,454
+12,198
| +287% | +$111K | ﹤0.01% | 2324 |
|
|
2021
Q1 | $40.1K | Buy |
+4,256
| New | +$40.1K | ﹤0.01% | 2287 |
|
|
2020
Q3 | – | Sell |
-15,554
| Closed | -$103K | – | 2341 |
|
|
2020
Q2 | $103K | Buy |
15,554
+2,612
| +20% | +$17.3K | ﹤0.01% | 2241 |
|
|
2020
Q1 | $75.3K | Buy |
+12,942
| New | +$75.3K | ﹤0.01% | 2198 |
|
|
2019
Q4 | – | Sell |
-13,449
| Closed | -$116K | – | 2336 |
|
|
2019
Q3 | $116K | Hold |
13,449
| – | – | ﹤0.01% | 2250 |
|
|
2019
Q2 | $150K | Buy |
+13,449
| New | +$150K | ﹤0.01% | 2192 |
|